IL6 and pulmonary arterial hypertension: Humbert et al. showed increased serum levels of IL-6 compared to controls and chronic obstructive pulmonary disease associated PAH (COPD-aPAH) patients, suggesting that IL-6 may be an important mediator in PAH (61).